A modern Glycoproduct portfolio for the Omics Era
The omics fields such as glycomics and glycoproteomics are generating tremendous amounts of data in addition to the well-established genomics, transcriptomics, proteomics, lipidomics and metabolomics fields. Integration of the various ‘omics’ fields is moving science toward an holistic understanding of cellular biology in health and disease. Carbohydrates are at the interface of these fields.
Sussex Research Laboratories Inc. has developed a modern glyco product portfolio designed to help researchers explore glycobiology for glycotherapeutic applications. We translate complex carbohydrate chemistries into unique, leading-edge products designed to help researchers explore and exploit glycobiology with a view to advancing the field and creating new biomedical applications that advance human health.
Virtually countless applications… from GalNAc ligands recognized by asialo glycoprotein receptors (ASGPR) to glycopeptides for cancer immunotherapies to glycoconjugation for preclinical vaccine development.
Take a moment to peruse the portfolio. If we don’t have what you are looking for, kindly drop us a note and we’ll see what we can do for you by way of a new product introduction or a custom synthesis.
Searched for: bt900200